Top 5 High Dividend Stocks For 2014

Stocks that pay dividends have never been more popular, especially among investors looking for as much income as they can generate from their portfolios. If you're a dividend investor, you need to know that the stocks you choose will give you dependable income not only now but well into the future.

What not to focus on
The mistake that many dividend investors make is to pay too much attention to current yield. Admittedly, if you need income right now, then the temptation to get instant gratification from a high-yielding dividend stock can be overwhelming.

But all too often, stocks that pay high dividends end up having to cut their payouts. By contrast, stocks that have demonstrated their ability provide strong growth in their dividends -- even if their yields aren't as high -- give investors more assurance that those stocks will be able to sustain their payouts going forward.

With that in mind, let's turn to four stocks that have attractive yields of 3% or more yet have been able to produce impressive dividend growth at a 10% or greater annual clip for the past decade.

Top Integrated Utility Companies To Buy Right Now: Violin Memory Inc (VMEM)

Violin Memory, Inc., incorporated on March 9, 2005, is pioneering a new class of flash-based storage systems that are designed to bring storage performance in-line with high-speed applications, servers and networks. The Company�� Flash Memory Arrays are specifically designed at each level of the system architecture starting with memory and optimized through the array to leverage the inherent capabilities of flash memory and meet the sustained requirements of business-critical applications, virtualized environments and Big Data solutions in enterprise data centers. The Company�� Velocity Peripheral Component Interconnect Express (PCIe), Flash Memory Cards leverage its persistent memory-based architecture in servers and are optimized for applications that require continuous access to quantities of low latency persistent memory located directly in servers.

The Company�� storage systems are based on a four-layer hardware architecture, which is integrated with its Violin Memory Operating System (vMOS), software stack to optimize the management of flash memory at each level of its system architecture. The Company�� Velocity PCIe Flash Memory Cards leverage its expertise in persistent memory-based storage and controller design, as well as its vMOS software stack, to offer a differentiated architecture in a deployable PCIe form factor.

Advisors' Opinion:

• [By Michael Calia]

  Violin Memory Inc.(VMEM) named Kevin A. DeNuccio as chief executive after firing prior CEO Don Basile in December because of the company’s poor performance. The flash-storage company posted disappointing third-quarter results and a sagging stock price.

• [By Eric Volkman]

  Getty Images/Cultura As more than a few finance industry professionals will happily brag, 2013 was a banner year for initial public offerings with 156 new stocks coming to market -- the most since 2007 -- collectively reaping the issuers aggregate proceeds of more than $38 billion. We went over the most recognizable members of this year's rookie class in "The 5 Most Unfortgettable IPOs of 2013." But in a big pool of 156 companies, there are bound to be at least a few struggling fish. Here, then, is a selection of five from the class of 2013 that are getting seriously lapped by their peers. 1. Prosensa (RNA) This Dutch clinical-stage biopharmaceutical firm had a strong debut when it listed on the Nasdaq in late June. The stock's offer price of $13 zoomed to close at over $19 on the first day of trading. But bad news was waiting around the corner; less than three months later, the shares tanked by more than 70 percent after the company announced that the muscular dystrophy treatment (drisapersen) it was developing in partnership with GlaxoSmithKline (GLAXF), did not hit its primary endpoint in late-stage trials. That one-day free fall saw the stock swoon from $24 per share to barely over $7. Since then, shares have slipped even further, and can currently be had for less than $5. 2. Violin Memory (VMEM) As a provider of high-speed data storage solutions, this company should be well in tune with current IT needs. But it fell flat from the beginning -- on its first day of trading the stock closed slightly over $7 a share, after pricing at $9. Worse was to come when the firm reported its first quarterly results as a publicly traded entity. While revenue advanced nearly 40 percent on a year-over-year basis, that couldn't cover the gaping hole of a bottom line loss totaling $34 million (a figure, by the way, significantly higher than the top line number of $28 million). The already-sinking shares continued to dive, bottoming at just over $2.50 per share. The re

Top 5 High Dividend Stocks For 2014: NPS Pharmaceuticals Inc.(NPSP)

NPS Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for gastrointestinal and endocrine disorders, and various medical needs. The company?s primary clinical programs include two therapeutic peptides to restore or replace biological functions comprising GATTEX, a Phase 3 clinical trial product for short bowel syndrome; and Natpara, a recombinant human parathyroid hormone 1-84, which is in Phase 3 clinical development trials. It also develops NPSP790 and NPSP795 calcilytic compounds that are in Phase I trials for the treatment of rare endocrine disorders. The company has collaborative and license agreements with Amgen Inc., Janssen, GlaxoSmithKline, Kyowa Hakko Kirin, and Nycomed Danmark ApS. NPS Pharmaceuticals, Inc. was founded in 1986 and is based in Bedminster, New Jersey.

Advisors' Opinion:

• [By gurujx]

  NPS Pharmaceuticals Inc (NPSP): EVP & CFO Luke M Beshar Sold 50,000 Shares

  EVP & CFO Luke M Beshar sold 50,000 shares of NPSP stock on 09/20/2013 at the average price of $30.26. Luke M Beshar owns at least 59,180 shares after this. The price of the stock has increased by 7.01% since.

Top 5 High Dividend Stocks For 2014: Avino Silver & Gold Mines Ltd (ASM)

Avino Silver & Gold Mines Ltd. (Avino) is a natural resource company, primarily engaged in the acquisition, exploration and development of natural resource properties. The Company�� principal business activities include the exploration of a mineral property located in the State of Durango, Mexico and other mineral properties in Canada, specifically British Columbia and the Yukon Territory. The Company is focused on silver and gold exploration. As of December 31, 2011, the Company explored five silver and gold projects in Canada and Mexico. All of the Company�� mineral property interests in Canada are wholly owned by the Company. In Mexico, the Company has a 99.28% interest in Cia Minera, a Mexican company, which is involved in the mining of commercial ores and resource exploration and development, including the operation of the Avino Mine. Cia Minera is not involved with any exploration activities in Canada. Advisors' Opinion:

• [By abirk]

  Spirit's profits are signs of steady growth. Since 2010, Annual passenger revenue and net income have both increased steadily. Spirit generated 24.4% growth in revenue passenger miles (RPM), while the available seat miles (ASM), and grew 24.8%. On the other hand, Delta's mainland division had 8.6 million RPM. �On a revenue basis, Spirit is equivalent to about 3.2% of the total revenue of the combined Delta and US Airways, now part of American Airlines Group (AAL).

Top 5 High Dividend Stocks For 2014: OraSure Technologies Inc.(OSUR)

OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States and internationally. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. The company offers OraQuick ADVANCE HIV-1/2, a point-of-care qualitative test for antibodies to the human immunodeficiency virus type 1 and type 2; OraQuick HCV, a point-of-care qualitative test for antibodies to the hepatitis C virus; OraSure QuickFlu Rapid Flu A&B Test, a point-of-care qualitative test for antibodies to influenza Types A and B, including H1N1 infections; OraSure, an oral fluid collection device for the detection of antibodies to HIV-1 in an oral fluid sample in a laboratory setting; and Intercept, an oral fluid collection device for oral fluid drugs of abuse testing in a laboratory setting. In addition, it provides MICRO-PLATE DOA Assays that are used to detect the drugs in an oral fluid sample collected with intercept device; cryosurgical freezing systems for the removal of warts and other benign skin lesions; and cryosurgical systems for the removal of common and plantar warts. Further, OraSure Technologies sells immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test results obtained from the use of OraSure collection device; and Q.E.D., a point-of-care saliva alcohol test. The company sells its products through direct sales, strategic collaborations, and distributors to clinical laboratories, hospitals, clinics, community-based and other public health organizations, distributors, government agencies, physicians? offices, and commercial and industrial entities. It has collaboration agreement with Merck & Co. Inc. OraSure Technologies, Inc. was founded in 1979 and is based in Beth lehem, Pennsylvania.

Advisors' Opinion:

• [By Keith Speights]

  Progress has also been made on the diagnostic front. The FDA approved OraSure Technologies' (NASDAQ: OSUR  ) OraQuick home HIV test in July 2012. OraQuick allows an individual to use a mouth swab and find out the results within 40 minutes. The test hasn't exactly leaped off store shelves as of yet, though. OraSure reported only $1.5 million in gross sales for the OraQuick home test during the most recent quarter.

• [By Sam Collins]

  OraSure Technologies (OSUR) — This small-cap company develops, manufactures and markets oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.

• [By Seth Jayson]

  OraSure Technologies (Nasdaq: OSUR  ) reported earnings on May 8. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended March 31 (Q1), OraSure Technologies beat slightly on revenues and met expectations on earnings per share.